ストックスクリーナーアプリを入手
3.03
3.50%
-0.11
Abcellera Biologics Inc (ABCL) 最新ニュース
AbCellera reassigns COO to CTO role, dissolves position - Investing.com India
AbCellera Biologics Changes COO's Title to Technology Chief -February 18, 2025 at 12:57 pm EST - Marketscreener.com
AbCellera reassigns COO to CTO role, dissolves position By Investing.com - Investing.com South Africa
One AbCellera Biologics Insider Raised Their Stake In The Previous Year - Yahoo Finance
Abcellera Biologics, other AI health stocks gain as Ellison touts AI's promise - MSN
AbCellera Biologics Inc. (NASDAQ:ABCL) Short Interest Update - MarketBeat
AbCellera Biologics (ABCL) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
AbCellera Biologics (ABCL) to Release Earnings on Tuesday - MarketBeat
Moloney Securities Asset Management LLC Takes $265,000 Position in AbCellera Biologics Inc. (NASDAQ:ABCL) - MarketBeat
AbCellera Biologics (NASDAQ:ABCL) Shares Down 5%Time to Sell? - MarketBeat
AbCellera to Participate at Upcoming Investor Conferences in March - The Globe and Mail
Biotech in B.C. battles harsh market while landing big deals - Business in Vancouver
AbCellera Biologics (NASDAQ:ABCL) Shares Down 4%Here's Why - MarketBeat
AbbVie, AbCellera expand collaboration into T-cell engagers - MSN
ABCL (AbCellera Biologics) Shares Outstanding (EOP) : 295.16 Mil (As of Sep. 2024) - GuruFocus.com
JPMorgan Chase & Co. Acquires 21,483 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL) - Defense World
AbCellera Biologics (NASDAQ:ABCL) Shares Up 18.8%Here's What Happened - MarketBeat
AbCellera Biologics (NASDAQ:ABCL) Stock Price Up 18.8%Here's What Happened - MarketBeat
Abcellera Biologics Inc (ABCL-Q) QuotePress Release - The Globe and Mail
AbCellera to Report Full Year 2024 Financial Results on February 27, 2025 - BioSpace
AbCellera Biologics Inc. (NASDAQ:ABCL) most popular amongst individual investors who own 36% of the shares, institutions hold 29% - Yahoo Finance
AbCellera Biologics (NASDAQ:ABCL) Stock Price Up 10.5%Time to Buy? - MarketBeat
AbCellera Biologics (NASDAQ:ABCL) Stock Price Down 6.7%What's Next? - MarketBeat
AbCellera Biologics Inc. (ABCL): A Bull Case Theory - Insider Monkey
AbCellera Biologics (NASDAQ:ABCL) Trading Up 10.5%What's Next? - MarketBeat
AbCellera Biologics (NASDAQ:ABCL) Shares Down 6.7%Here's Why - MarketBeat
Geode Capital Management LLC Sells 201,213 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL) - Defense World
Geode Capital Management LLC Has $295,000 Stock Holdings in AbCellera Biologics Inc. (NASDAQ:ABCL) - MarketBeat
AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology - sharewise
AbCellera and AbbVie expand oncology collaboration - Investing.com
AbCellera and AbbVie expand oncology collaboration By Investing.com - Investing.com South Africa
KeyCorp Issues Pessimistic Forecast for AbCellera Biologics (NASDAQ:ABCL) Stock Price - Defense World
AbCellera Biologics (NASDAQ:ABCL) Price Target Cut to $4.00 by Analysts at KeyCorp - MarketBeat
AbCellera Biologics (NASDAQ:ABCL) Stock Price Down 7.9%What's Next? - MarketBeat
Is AbCellera Biologics Inc. (ABCL) Among the Best Canadian Penny Stocks to Buy According to Analysts? - Insider Monkey
12 Best Canadian Penny Stocks to Buy According to Analysts - Insider Monkey
AbCellera Biologics (NASDAQ:ABCL) Trading Up 7.2%Time to Buy? - MarketBeat
Stifel Financial Corp Has $195,000 Stock Holdings in AbCellera Biologics Inc. (NASDAQ:ABCL) - Defense World
AbCellera Biologics (NASDAQ:ABCL) Stock Price Down 6%What's Next? - MarketBeat
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):